Answers are grounded in this paper and cite their sources.
Cross-sectional analysis reveals urinary LTE4 links to decreased lung function in adult asthma phenotypes, suggesting TH2-driven inflammation.
Background: We tested if lipid mediator profiles could be used as biomarkers of certain phenotypes of asthma and measured the urinary concentrations of metabolites of the cysteinyl-leukotrienes (CysLTs), prostaglandins (PGs) and isoprostanes (IPs) at the cross-sectional baseline visit in the U-BIOPRED study of adults with asthma. Methods: Subjects (aged 18-79) with severe asthma (SA; n=231), mild-to-moderate asthma (MA; n=71) and healthy controls (HC; n=72) provided spot urine samples that were analysed using UPLC-MS/MS (Balgoma et al Anal Chem 2013). Results: The urinary excretion of all lipid mediators, except tetranorPGEM, were highest among SA, and generally higher in MA vs. healthy controls. LTE 4 displayed the highest median fold change (MFC) (MFC=2.1, P<0.001) for SA but also a significant change for MA (MFC=1.5, P<0.05). The markers of oxidative stress, isoprostane 8-iso-PGF 2α (MFC=1.6, P<0.001) and 2,3-dinor-8-iso-PGF 2α (MFC=1.3, P<0.01), were increase in smokers with SA (n=35). Prediction accuracy of SA vs HC in a in a multivariate OPLS-DA model was high (87% overall, 91 % for SA and 72 % for HC) with highest model contribution of LTE 4 >and tetranorPGDM. The subjects with the highest 25 th percentile of urinary LTE 4 had a highly significant lower lung function than those in the lowest 25 th percentile (FEV 1 % predicted being 58.9 ± 26.7 vs 106.6 ± 11.3) . Moreover, urinary LTE 4 levels correlated with high total IgE, exhaled NO and eosinophils in sputum or blood. Conclusion: Increased urinary LTE 4 was associated with decreased baseline lung function and suggestive of a Th2 profile of airway inflammation.
No takes yet. Share an insight, caveat, or question.
Sjödin et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: